Company News: Page (1) of 1 - 05/16/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook

Lilly Data at ASCO Illustrate Patient-Driven Advances in Cancer Care

First presentation of findings from the ramucirumab REACH-2 study - the first positive Phase 3 hepatocellular carcinoma trial in a biomarker-selected populationResearch across the MONARCH clinical dev... (May 16, 2018)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:Pro AV,Management,Presentors,Business Issues,Presentation,People,Events,USA,Medicine,Disease,healthcare,Cancer,Surgery,Womens Health,Science,Theater,Medical,Cancer,Other,Women,

-->

Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved